Treatment of psoriasis with interferon induced Helicase C domain 1 (IFIH1) inhibitors
Grant
US12584174B2
Kind: B2
Mar 24, 2026
Assignee
Regeneron Pharmaceuticals, Inc.
Inventors
Julie E. Horowitz, Manuel Allen Revez Ferreira, Katherine Siminovitch, Aris Baras, Lori Khrimian, Katia Karalis
Abstract
The present disclosure provides methods of treating subjects having psoriasis, and methods of identifying subjects having an increased risk of developing psoriasis.
CPC Classifications
C12Q 1/6883
C12Q 2600/118
C12Q 2600/156
A61K 31/7105
A61K 38/465
A61K 45/06
A61K 31/713
A61K 31/7088
A61K 48/00
C12N 15/1138
C12N 2310/11
C12N 2310/14
C12N 2310/531
C12N 2320/31
C12N 2310/20
C12N 15/1137
C12N 15/113
C12N 9/22
C12Y 306/04013
C12Y 203/02
A61P 17/06
Filing Date
2022-06-09
Application No.
17836735
Claims
3